Aditya Desai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aditya Desai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aalamnoor Pannu
USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications - Conner Ganjavi
USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications - Ethan Layne
USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications - Gerhard Fuchs
USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications - Giovanni Enrico Cacciamani
USC Institute of Urology, University of Southern California, Los Angeles, USA
2 shared publications - Gus Miranda
USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (12) , 696
Readability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study
Accessible health information is essential to promote patient engagement and informed participation in clinical research. Brief summaries on ClinicalTrials.gov are indented for lay people; however they are often written at a reading level that is too advanced for the public. This study evaluated the performance of a Generative Artificial Intelligence (GAI)-powered tool—Pub2Post—in producing readable and complete layperson brief summaries for urologic oncology clinical trials. Twenty actively recruiting clinical trials on prostate, bladder, kidney, and testis cancers were retrieved from ClinicalTrials.gov. For each, a GAI-generated summary was produced and compared with its publicly available counterpart. Readability indices, grade-level indicators, and text metrics were analyzed alongside content inclusion across eight structural domains. GAI-generated summaries demonstrated markedly improved readability (mean FRES 73.3 ± 3.5 vs. 17.0 ± 13.1; p < 0.0001), aligning with the recommended middle-school reading level, and achieved 100% inclusion of guideline-defined content elements. GAI summaries exhibited simpler syntax and reduced lexical complexity, supporting improved comprehension. These findings suggest that GAI tools such as Pub2Post can generate patient-facing summaries that are both accessible and comprehensive.
- 10 December 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (12) , 696
Open AccessReadability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study
Accessible health information is essential to promote patient engagement and informed participation in clinical research. Brief summaries on ClinicalTrials.gov are indented for lay people; however they are often written at a reading level that is too advanced for the public. This study evaluated the performance of a Generative Artificial Intelligence (GAI)-powered tool—Pub2Post—in producing readable and complete layperson brief summaries for urologic oncology clinical trials. Twenty actively recruiting clinical trials on prostate, bladder, kidney, and testis cancers were retrieved from ClinicalTrials.gov. For each, a GAI-generated summary was produced and compared with its publicly available counterpart. Readability indices, grade-level indicators, and text metrics were analyzed alongside content inclusion across eight structural domains. GAI-generated summaries demonstrated markedly improved readability (mean FRES 73.3 ± 3.5 vs. 17.0 ± 13.1; p < 0.0001), aligning with the recommended middle-school reading level, and achieved 100% inclusion of guideline-defined content elements. GAI summaries exhibited simpler syntax and reduced lexical complexity, supporting improved comprehension. These findings suggest that GAI tools such as Pub2Post can generate patient-facing summaries that are both accessible and comprehensive.
- Open Access
- 11 October 2025
- Published by MDPI AG in Preprints.org
Readability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study
Accessible health information is essential to promote patient engagement and informed participation in clinical research. Brief summaries on ClinicalTrials.gov are indented for lay people, however are often written at a reading level that is too advanced for the public. This study evaluated the performance of a Generative Artificial Intelligence (GAI) powered tool - Pub2Post-, in producing readable and complete layperson brief summaries for urologic oncology clinical trials. Twenty actively recruiting clinical trials on prostate, bladder, kidney, and testis cancers were retrieved from ClinicalTrials.gov. For each, a GAI-generated summary was produced and compared with its publicly available counterpart. Readability indices, grade-level indicators, and text metrics were analyzed alongside content inclusion across eight structural domains. GAI-generated summaries demonstrated markedly improved readability (mean FRES 73.3 ± 3.5 vs. 17.0 ± 13.1; p < 0.0001), aligning with the recommended middle-school reading level, and achieved 100% inclusion of guideline-defined content elements. GAI summaries exhibited simpler syntax and reduced lexical complexity, supporting improved comprehension. These findings suggest that GAI tools such as Pub2Post can generate patient-facing summaries that are both accessible and comprehensive.
- 11 October 2025
- Published by MDPI AG in Preprints.org
Open AccessReadability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study
Accessible health information is essential to promote patient engagement and informed participation in clinical research. Brief summaries on ClinicalTrials.gov are indented for lay people, however are often written at a reading level that is too advanced for the public. This study evaluated the performance of a Generative Artificial Intelligence (GAI) powered tool - Pub2Post-, in producing readable and complete layperson brief summaries for urologic oncology clinical trials. Twenty actively recruiting clinical trials on prostate, bladder, kidney, and testis cancers were retrieved from ClinicalTrials.gov. For each, a GAI-generated summary was produced and compared with its publicly available counterpart. Readability indices, grade-level indicators, and text metrics were analyzed alongside content inclusion across eight structural domains. GAI-generated summaries demonstrated markedly improved readability (mean FRES 73.3 ± 3.5 vs. 17.0 ± 13.1; p < 0.0001), aligning with the recommended middle-school reading level, and achieved 100% inclusion of guideline-defined content elements. GAI summaries exhibited simpler syntax and reduced lexical complexity, supporting improved comprehension. These findings suggest that GAI tools such as Pub2Post can generate patient-facing summaries that are both accessible and comprehensive.